Last mentioned: Feb 26, 2026
Q4 2025 Earnings Call
Management discusses year-end results and provides guidance for the 2026 fiscal year.
Dividend Declaration
Board of Directors declares a $0.09 per share dividend, signaling financial stability.
MDA SHIELD Contract
Leonardo DRS awarded a position on the Missile Defense Agency's SHIELD IDIQ contract.
Leonardo DRS reported strong Q4 2025 performance, bolstered by critical wins in missile defense and a steady expansion of its naval propulsion business. The company's declaration of a $0.09 dividend reflects growing confidence in its long-term role within the U.S. Navy's submarine modernization programs.
This page surfaces every story mentioning Avanos Medical across our space & defense coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running space & defense beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Avanos Medical was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |